Pharma Tech Outlook: Top 20 CROs of 2024
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs
Pragmatic Considerations for the Application of Physical Withdrawal Assessments in Patient Studies
Up Close and Personal With Ashley (Schnider) Mahoney, Study Director, Scientist
Ashley joined Altasciences in 2022 as Study Director.
My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference
My fellow Altascientists and I recently attended the 2024 annual Boston Society Gen